↧
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
全身型若年性特発性関節炎の新適応で「イラリス皮下注」が効能追加承認を取得
ノバルティス ファーマ株式会社（本社：東京都港区虎ノ門）は7月2日、クリオピリン関連周期性症候群（CAPS）治療薬「イラリス®皮下注用150mg」、及び「イラリス®皮下注射液150mg（一般名：カナキヌマブ［遺伝子組換え］）」について、全身型若年性特発性関節炎（SJIA＝systemic juvenile idiopathic...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.